Rapid Infuser Market Size, Share, Growth Report 2032

Introduction

The rapid infuser market is set for a rapid growth over the forecast period. In terms of revenue, the global rapid infuser market accounted for USD 790.55 Million in 2019 and is expected to reach USD 1,029.36 Million by 2026, growing at a CAGR of 3.84%.

Global Rapid Infuser Market: Overview

A rapid infuser is a surgical procedure or treatment that incorporates the administration of a rapid fluid. The rapid infuser system can deliver fluid (human body fluid) in a slow to rapid continuous flow. In emergency cases, rapid infuser system is widely used to provide effective and safe treatment to patients facing with excessive blood loss or hypovolemic shock. There are two main types of rapid infuser devices: one that is operated by a compressor and the other that is attached to hospital wall pressurized outlets.

Request Free Sample

Global Rapid Infuser Market: Growth Factors

The most convenient and efficient way of supplying fluids in a short period of time is one of the major factors driving the global rapid infuser market. Moreover, due to product developments and the implementation of information and sensing technologies, the use of this system in anesthesia centres has increased over the years. Manufacturing companies in this industry are achieving patient care excellence through the integration of enhanced patient monitors, novel criteria, wireless systems, workflows, and optimized IT solutions. This has helped clinicians and anesthesiologists to practice and provide patients with personalized services. Manufacturing firms provide not only technologically innovative products, but also value-added services such as predictable patient treatment, access to clinical information, and, as a result, optimized reimbursement.

Also, the increase in the prevalence of chronic pulmonary diseases is hastening market development. According to recent World Health Organization (WHO) projections, Chronic Obstructive Pulmonary Disease (COPD) will be the third major cause of death by 2030. In 2016, there were 251 million COPD cases globally, according to the Global Burden of Disease Study. In 2015, the disease is estimated to have killed 3.17 million people worldwide, accounting for 5% of all deaths that year. An increase in the geriatric population suffering from COPD and asthma is expected to drive the growth of the rapid infuser market. The increased number of surgeries necessitates the production of rapid infuser systems.

The Centers for Disease Control and Prevention (CDC) reported that nearly 51.4 million surgical procedures were conducted in the United States in 2010. This covered 1.01 million cardiac catheterizations, 1.1 million small intestine endoscopic procedures (with or without biopsy), 499,000 large intestine endoscopic procedures (with or without biopsy), 719,000 knee replacements, 395,000 coronary artery bypass grafts (CABG), and 332,000 total hip replacements. It also revealed that the figure will grow in the near future. However, hospitals' sluggish adoption of rapid infuser devices is expected to stymie market development.

Global Rapid Infuser Market: Segmentation

Rapid infusers are divided into three categories based on their product type: trolley mounted devices, accessories, and handheld devices. The trolley mounted devices held a significant share in 2020 and is expected to grow at a notable rate in the near future. Portability and easy use of these devices have made them an ideal option for operations in professional healthcare settings, contributing to the growth of the market during the forecast period.

Rapid infuser is divided into two types based on their usability: single-use and reusable. Reusable rapid infuser systems are projected to be in high demand for the near future, due to significant cost savings for healthcare facilities. However, in the short term, the current pandemic is likely to reduce sales of reusable options in favour of single-use alternatives.

Rapid infusers are essential in hospitals, ambulatory surgical centers, and specialty clinics. The hospital segment held the largest share in 2020 and is expected to expand at a rapid pace in the coming years. Investments in healthcare infrastructure from the public and private sectors, as well as the use of rapid infusers in premium hospitals, emergency care units, and intensive care units, are major factors driving growth.

Rapid Infuser Market: Report Scope

Global Rapid Infuser Market: Regional Analysis

By Geography, the rapid infuser market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

North America held the largest revenue for global rapid infuser market in 2020. Access to cutting-edge healthcare technologies, stringent healthcare legislation, and advancements in patient care are all main factors moving the industry forward. Lifestyle-related disorders, as well as cases of trauma and injury, are key factors driving demand for rapid infusers in North American healthcare facilities, with the United States accounting for a sizable market share. Moreover, the North American rapid infusers market is expected to benefit from regular technological advancements, allowing offerings to respond to patients with diverse healthcare needs. Furthermore, North America is home to a variety of market players, which assists in market positioning consolidation.

Europe is the second-largest market for rapid infusers. A strong healthcare infrastructure is a major factor contributing to the growth of rapid infuser in the European Union (EU) countries. The need for cost-cutting in healthcare facilities, as well as the increasing number of surgical procedures performed in the region, would drive long-term growth in the European rapid infusers market. Also, the increasing demand for home healthcare not only in the EU, but also in developing central and eastern European markets, is expected to create opportunities for players in the coming years.

Rapid infusers have a strong presence in Asia Pacific, which is growing at a faster rate than the rest of the world. Rapid infusers are becoming more common as healthcare professionals and patients are becoming more aware of quality and safety requirements. The region's large population base, the emergence of the middle-class families, and healthcare coverage expansion are projected to show a positive growth trajectory. With low-cost labour, strengthened intellectual property protections, and substantial research and innovation investments, Asia Pacific has emerged as a leading MedTech hub. Rapid infuser penetration in the region is still limited, allowing for significant market expansion opportunities. Domestic players will face less competition, which will benefit market leaders.

Global Rapid Infuser Market: Competitive Players

The major players in the global rapid infuser market include:

• 3M
• Stryker Corporation
• GE Healthcare Inc
• Smith’s Group plc.
• (Smiths Medical)
• ZOLL Medical Corporation
• Teleflex Incorporated
• Belmont Instrument Corporation
• Becton
• Dickinson and Company (BD)
• Soma Technology, Inc
• 410 Medical
• Smisson-Cartledge Biomedical among others.

The report segment of global rapid infuser market are as follows:

Global Rapid Infuser Market: Product Type Segment Analysis

• Handheld Devices
• Trolley Mounted Devices
• Accessories

Global Rapid Infuser Market: Usability Segment Analysis

• Single Use
• Reusable

Global Rapid Infuser Market: End-User Segment Analysis

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centres (ASCs)

Global Rapid Infuser Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa